(0.41%) 5 112.25 points
(0.79%) 38 686 points
(0.68%) 17 770 points
(0.49%) $79.34
(0.44%) $2.04
(-0.13%) $2 306.50
(-0.67%) $26.65
(0.84%) $970.70
(-0.70%) $0.926
(-1.60%) $10.82
(-0.72%) $0.792
(0.50%) $91.59
4 days till quarter result
(bmo 2024-05-07)
Expected move: +/- 0.00%
-1.28% SEK 0.541
Live Chart Being Loaded With Signals
Active Biotech AB (publ), a biotechnology company, develops pharmaceutical products the treatment of oncology and immunology diseases in Sweden. It is developing Tasquinimod, a small molecule immuno-modulator, which is in Phase Ib/IIa clinical trial to treat multiple myeloma; Laquinimod, an immunomodulator that is in phase I clinical trial for the treatment of inflammatory eye disorders, including uveitis; and Naptumomab, an anti-cancer immunotherapy, which is in phase Ib/II clinical trial to treat patients with advanced solid tumors...
Stats | |
---|---|
Dzisiejszy wolumen | 99 413.00 |
Średni wolumen | 489 667 |
Kapitalizacja rynkowa | 204.72M |
EPS | SEK0 ( 2024-02-07 ) |
Następna data zysków | ( SEK0 ) 2024-05-07 |
Last Dividend | SEK0 ( N/A ) |
Next Dividend | SEK0 ( N/A ) |
P/E | -3.18 |
ATR14 | SEK0.00600 (1.11%) |
Active Biotech AB (publ) Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Active Biotech AB (publ) Finanse
Annual | 2023 |
Przychody: | SEK0 |
Zysk brutto: | SEK-1.68M (0.00 %) |
EPS: | SEK-0.170 |
FY | 2023 |
Przychody: | SEK0 |
Zysk brutto: | SEK-1.68M (0.00 %) |
EPS: | SEK-0.170 |
FY | 2022 |
Przychody: | SEK0 |
Zysk brutto: | SEK-1.49M (0.00 %) |
EPS: | SEK-0.230 |
FY | 2021 |
Przychody: | SEK0.00 |
Zysk brutto: | SEK0.00 (0.00 %) |
EPS: | SEK-0.240 |
Financial Reports:
No articles found.
Active Biotech AB (publ)
Active Biotech AB (publ), a biotechnology company, develops pharmaceutical products the treatment of oncology and immunology diseases in Sweden. It is developing Tasquinimod, a small molecule immuno-modulator, which is in Phase Ib/IIa clinical trial to treat multiple myeloma; Laquinimod, an immunomodulator that is in phase I clinical trial for the treatment of inflammatory eye disorders, including uveitis; and Naptumomab, an anti-cancer immunotherapy, which is in phase Ib/II clinical trial to treat patients with advanced solid tumors. The company has a licensing agreement with NeoTX Therapeutics Ltd. for the development and commercialization of Naptumomab for cancer immunotherapy. Active Biotech AB (publ) was incorporated in 1983 and is headquartered in Lund, Sweden.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej